Keyword Connections

non-alcoholic fatty liver disease

Journals

7

1 arthritis research & therapy

2 journal of hepatology

3 lipids in health and disease

4 Journal of cellular and molecular medicine

5 Disease models & mechanisms

6 nutrition (burbank, los angeles county, calif)

7 Naunyn-Schmiedeberg's Archives of Pharmacology

Research Groups

0

No Research Group Connected

Bibliographies

26

1 Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease.

2 Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.

3 NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.

4 Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.

5 Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.

6 ft3/ft4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism

7 therapeutic correction of liver and biliary tract pathology among adolescents with obesity

8 diabetes mellitus type 2: how to avoid errors and to increase the effectiveness of rreatment

9 Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

10 TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population.

11 Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

12 Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease

13 Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings.

14 Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

15 New dual peroxisome proliferator activated receptor agonist - Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence

16 Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease.

17 Potential implications of COVID-19 in non-alcoholic fatty liver disease.

18 how useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?

19 associação entre doença hepática gordurosa não alcoólica e marcadores de lesão/função hepática com componentes da síndrome metabólica em indivíduos obesos classe iii association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class iii obese individuals

20 predictors of liver fat and stiffness in non-alcoholic fatty liver disease (nafld) – an 11-year prospective study

21 role of bariatric surgery in treatment of non-alcoholic fatty liver disease

22 lifestyle interventions for the treatment of non-alcoholic fatty liver disease

23 risk factors for non-alcoholic fatty liver disease: a multivariate analysis

24 n-3 pufa status predicts non-alcoholic fatty liver disease (nafld) in older australians

25 non-alcoholic fatty liver disease (nafld) in different populations: a clinical and epidemiological study – sample of são josé do rio preto

26 influence of nutrient correction on adiponectin circulating level and cardiovascular risk factors in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease